脑淀粉样血管病相关凸面蛛网膜下腔出血后脑出血与死亡风险
本研究比较了脑淀粉样血管病(CAA)患者发生凸面蛛网膜下腔出血(cSAH)后与脑叶出血(ICH)后未来症状性ICH、cSAH和死亡的风险。纳入105例很可能CAA患者(44例cSAH,61例脑叶ICH),中位随访22.2个月。结果显示cSAH后症状性ICH年发生率为10.5%,与脑叶ICH后的8.5%相似,长期死亡风险亦无显著差异,提示CAA相关cSAH预后不良。
要点
- CAA相关cSAH后症状性ICH年发生率为10.5%,与脑叶ICH后8.5%相近。
- cSAH后长期死亡风险与脑叶ICH后无显著差异,预后均较差。
- cSAH应被视为CAA的重要临床表现,需重视其高出血和死亡风险。
核心结论
- CAA相关cSAH患者预后不良,未来症状性ICH和长期死亡风险与CAA脑叶ICH后相似。
研究设计与样本
- 连续纳入基于Boston标准很可能CAA且表现为cSAH或脑叶ICH的患者,共105例(cSAH 44例,ICH 61例),中位随访22.2个月。
主要发现
- 症状性ICH年发生率:cSAH组10.5%(95%CI 5.6-19.4),ICH组8.5%(95%CI 4.4-16.4),调整后HR 1.05(95%CI 0.32-3.43)。
- 症状性cSAH年发生率:cSAH组9.9%,ICH组3.8%,调整后HR 1.77(95%CI 0.43-7.28)。
- 死亡年发生率:cSAH组9.5%,ICH组17.8%,调整后HR 0.56(95%CI 0.22-1.43)。
临床怎么用
- 对CAA相关cSAH患者应认识到其与脑叶ICH相似的再出血和死亡风险,加强预后评估与随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Convexity subarachnoid hemorrhage (cSAH) is an increasingly recognized presentation of cerebral amyloid angiopathy (CAA), usually revealed by transient symptoms, but data on its outcome are limited. We compared the risk of future intracerebral hemorrhage (ICH), cSAH, and death in patients with CAA after cSAH and after lobar ICH. Methods- Consecutive patients with probable CAA, based on the Boston criteria, presenting with cSAH (CAA-cSAH) or lobar ICH (CAA-ICH) were included. We obtained baseline clinical and magnetic resonance imaging data and follow-up information. Univariable and multivariable analyses were used to compare incidence rate for symptomatic ICH, symptomatic cSAH, and late-death (beyond 30 days) between patients with CAA-cSAH and CAA-ICH. Results- Among 105 patients (mean age, 76.7±7.5 years) enrolled, 44 participants presented with CAA-cSAH and 61 with CAA-ICH. The median follow-up was 22.2 months (interquartile range, 12.6-34.4). The symptomatic ICH rate (per person-year) was 10.5% (95% CI, 5.6-19.4) in patients with CAA-cSAH compared with 8.5% (95% CI, 4.4-16.4) in those with CAA-ICH (adjusted hazard ratio, 1.05; 95% CI, 0.32-3.43). The annual incidence rates of symptomatic cSAH (9.9% versus 3.8%; adjusted hazard ratio, 1.77; 95% CI, 0.43-7.28) and death (9.5% versus 17.8%; adjusted hazard ratio, 0.56; 95% CI, 0.22-1.43) were not significantly different between patients with CAA-cSAH and those with CAA-ICH. Conclusions- Patients with CAA-related cSAH have a poor outcome, with similar high risk of future ICH and long-term mortality than CAA patients after lobar ICH. Our findings may have important prognostic implication and guide management of patients with cSAH in CAA.
引用
- Calviere L, Viguier A, Patsoura S, et al. Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy. Stroke. 2019. PMID: 31337297. doi:10.1161/STROKEAHA.119.026244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。